Compugen Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CGEN | CHRS | PYXS | ADAG | MGNX | PDSB | |
|---|---|---|---|---|---|---|
| Market cap | 192.29M | 131.36M | 198.30M | 161.82M | 147.15M | 136.51M |
| P/E (TTM) | 5.3 | — | — | — | — | — |
| Forward P/E | -5.5 | -1.3 | -1.5 | -4.3 | -1.6 | -6.8 |
| Price/book | 2.2 | 2.2 | 9.2 | 1.8 | 3.4 | -20.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +22.56% | −48.50% | −58.06% | +56.67% | +61.81% | +55.80% |
| Today | +1.00% | +5.54% | +1.22% | +2.55% | −0.86% | −7.80% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CGEN news ›Reviewing Pliant Therapeutics (NASDAQ:PLRX) & Compugen (NASDAQ:CGEN)
Posted by Defense World Staff on Oct 26th, 2026 Compugen (NASDAQ:CGEN – Get Free Report) and Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare…
Compugen’s (CGEN) “Buy” Rating Reiterated at HC Wainwright
Posted by Kim Johansen on Oct 15th, 2026 HC Wainwright reiterated their buy rating on shares of Compugen (NASDAQ:CGEN – Free Report) in a research report released on Monday,Benzinga reports. HC Wainwright currently has a $4.00 price…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- defenseworld.net2
- prnewswire.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.